EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation

Michela Giustozzi, Giancarlo Agnelli, Silvia Quattrocchi, Monica Acciarresi, Andrea Alberti, Valeria Caso, Maria Cristina Vedovati, Michele Venti, Maurizio Paciaroni

Cerebrovascular Diseases Extra · 06.05.2020 · 10 (2) · 44-49

DOI: 10.1159/000506923 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cerebrovascular Diseases Extra, online erschienen am 06.05.2020. Verfasst von Michela Giustozzi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy, michelagiustozzi…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Even though the introduction of less cumbersome anticoagulant agents has improved, the rates ofoverall anticoagulant treatment in eligible patients with atrial fibrillation (AF) remain to be defined. We aimed to assess the rates of and determinants for the use of anticoagulation treatment before stroke in patients with known AF since the introduction of direct oral anticoagulants (DOAC) in clinical practice.

Methods

Consecutive patients admitted to an individual stroke unit, from September 2013 through July 2019, for acute ischemic stroke or transient ischemic attack (TIA) with known AF before the event were included in the study. Logistic regression analysis was used to identify independent predictors of the use of anticoagulant treatment.

Results

Overall, 155 patients with ischemic stroke/TIA and known AF were included in this study. Among 152 patients with a CHA2DS2-VASc score >1, 43 patients were not receiving any treatment, 47 patients were receiving antiplatelet agents, and the remaining 62 patients were on oral anticoagulants. Among 34 patients on DOAC, 13 were receiving a nonlabeled reduced dose and 18 out of 34 patients on vitamin K antagonists had an INR value <2 at the time of admission. Before stroke, only 34 out of 155 patients (21.9%) were adequately treated according to current guidelines. Previous stroke/TIA was the only independent predictor of the use of anticoagulant therapy.

Conclusions

Only 21.9% of the patients hospitalized for a stroke or TIA with known AF before the event were adequately treated according to recent treatment guidelines. It is important to improve medical information about the risk of AF and the efficacy of anticoagulants in stroke prevention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Administration, OralAgedAged, 80 and overAnticoagulantsAtrial FibrillationDrug UtilizationFactor Xa InhibitorsFemaleGuideline AdherenceHumansIschemic Attack, TransientItalyMalePatient AdmissionPractice Guidelines as TopicPractice Patterns, Physicians'Risk AssessmentRisk FactorsStrokeTime Factors

Stichwörter der Autor:innen

Antithrombotic treatmentAtrial fibrillationOral anticoagulantsStroke

Substanzen

AnticoagulantsFactor Xa Inhibitors

Autor:innen und Institutionen

  • Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy, michelagiustozzi@hotmail.it.
  • Stroke Unit and Division of Cardiovascular Medicine, University of Perugia, Santa Maria della Misericordia Hospital, Perugia, Italy.

Zitieren

APA

Giustozzi, M., Agnelli, G., Quattrocchi, S., Acciarresi, M., Alberti, A., Caso, V., Vedovati, M. C., Venti, M., & Paciaroni, M. (2020). Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation. Cerebrovascular Diseases Extra, 10(2), 44-49. https://doi.org/10.1159/000506923

Vancouver

Giustozzi M, Agnelli G, Quattrocchi S, Acciarresi M, Alberti A, Caso V, et al. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation. Cerebrovascular Diseases Extra. 2020;10(2):44-49. doi:10.1159/000506923

BibTeX
@article{Giustozzi2020,
  author = {Giustozzi, Michela and Agnelli, Giancarlo and Quattrocchi, Silvia and Acciarresi, Monica and Alberti, Andrea and Caso, Valeria and Vedovati, Maria Cristina and Venti, Michele and Paciaroni, Maurizio},
  title = {Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation},
  journal = {Cerebrovascular Diseases Extra},
  year = {2020},
  volume = {10},
  number = {2},
  pages = {44--49},
  doi = {10.1159/000506923}
}
Kostenlos starten →